Type 1 diabetes is a chronic autoimmune condition in which the immune system destroys the insulin-producing cells in the pancreas. Without insulin, the body cannot move sugar from the bloodstream into cells for energy, so blood sugar rises to dangerous levels. Unlike type 2 diabetes, which involves insulin resistance, type 1 diabetes means the body produces little to no insulin at all. It accounts for roughly 5 to 10 percent of all diabetes cases and requires lifelong insulin replacement.
What Causes Type 1 Diabetes
The root cause is an immune system malfunction. White blood cells, which normally fight infections, mistakenly attack the beta cells in the pancreas. These beta cells are the only cells in the body that make insulin. By the time symptoms appear, about 80 to 90 percent of them have already been destroyed.
Genetics play a major role. Specific gene variations in the HLA region of chromosome 6 account for about 50 percent of the inherited risk. Beyond those, genome-wide studies have identified more than 50 additional gene regions that contribute smaller amounts of risk. But genes alone don’t seal the deal. Identical twins share the same DNA, yet when one twin has type 1 diabetes, the other develops it only about 30 to 50 percent of the time. Something in the environment has to pull the trigger.
The leading environmental suspect is a group of common gut viruses called enteroviruses. Chronic infection with these viruses has been linked to a nearly tenfold increase in the risk of developing type 1 diabetes. A clinical trial using a vaccine against multiple enterovirus strains is now being planned to test whether blocking these infections could prevent the disease. Other factors under investigation include changes in gut bacteria diversity and early childhood diet, though none has been proven to cause the condition on its own.
Who Gets It and When
Type 1 diabetes was once called “juvenile diabetes” because it often appears in childhood or adolescence. That name is misleading. Data from the International Diabetes Federation show that 62 percent of all new type 1 diabetes cases in 2022 occurred in people aged 20 or older. Adults can and do develop it, sometimes well into middle age. It affects all ethnicities, though rates are highest in people of Northern European descent.
Symptoms and How They Develop
Symptoms typically develop fast, over days to weeks, rather than the slow onset common in type 2 diabetes. The classic signs form a recognizable pattern: excessive thirst, frequent urination, and increased hunger paired with unexplained weight loss. The body, unable to use sugar for fuel, starts breaking down fat and muscle instead, which explains the weight loss even when appetite increases.
Other common early symptoms include fatigue, blurred vision, slow-healing cuts, and fruity-smelling breath. In children, bedwetting in a previously dry child is sometimes the first clue parents notice. Because symptoms escalate quickly, type 1 diabetes is sometimes diagnosed in an emergency setting when a person arrives in a state called diabetic ketoacidosis, where the blood becomes dangerously acidic from the buildup of ketones (a byproduct of burning fat for energy).
How It’s Diagnosed
A basic blood sugar test can confirm diabetes, but distinguishing type 1 from type 2 requires additional testing. Doctors look for autoantibodies, proteins that signal an immune attack on the pancreas. The most commonly tested include antibodies targeting an enzyme called GAD65, as well as antibodies against IA-2 and ZnT8 proteins. Finding one or more of these strongly points to type 1.
A C-peptide test adds another layer of certainty. C-peptide is a molecule released alongside insulin during production, so measuring it reveals how much insulin the pancreas is actually making. In type 1 diabetes, C-peptide levels are very low or undetectable. This test is especially useful when the diagnosis is unclear, such as in adults who might initially be misdiagnosed with type 2.
The Honeymoon Phase
Shortly after diagnosis and the start of insulin therapy, many people experience a temporary improvement known as the honeymoon phase. During this period, the remaining beta cells partially recover. The leading explanation is that once injected insulin brings blood sugar down, the surviving beta cells get a break from the toxic effects of high blood sugar and begin functioning better for a time. Insulin doses may drop significantly, and blood sugar can become easier to manage.
This phase is temporary. It can last weeks to months, sometimes up to a year, but the immune attack continues in the background. Eventually the remaining beta cells are destroyed and insulin needs increase to their full level. Understanding this timeline matters because the honeymoon phase can create a false sense that the disease is improving or was misdiagnosed.
Daily Management
Everyone with type 1 diabetes needs insulin, either through multiple daily injections or an insulin pump worn on the body. There is no pill form of insulin because stomach acid breaks it down before it can work. Managing the condition involves a constant balancing act: matching insulin doses to the amount of carbohydrates eaten, physical activity levels, stress, illness, and dozens of other variables that affect blood sugar.
Continuous glucose monitors have changed daily life considerably. These small sensors, worn just under the skin, measure blood sugar every few minutes and send readings to a phone or receiver. Paired with an insulin pump, some systems can automatically adjust insulin delivery based on glucose trends, functioning as a partial “artificial pancreas.” Even with this technology, the mental load of managing type 1 diabetes is significant. Every meal, workout, and sick day requires active decision-making.
Low blood sugar (hypoglycemia) is the most immediate daily risk. It can happen when too much insulin is delivered relative to the sugar available in the blood. Mild episodes cause shakiness, sweating, and confusion. Severe episodes can lead to seizures or loss of consciousness. People with type 1 diabetes typically carry fast-acting sugar sources like glucose tablets at all times.
Long-Term Complications
Persistently high blood sugar over years damages blood vessels throughout the body. The complications fall into two categories based on which vessels are affected.
Small-vessel damage leads to three well-known complications. Retinopathy affects the blood vessels in the eyes and is a leading cause of vision loss; regular dilated eye exams every one to two years catch it early. Nephropathy, or kidney disease, develops in 20 to 40 percent of adults with diabetes as the tiny filtering units in the kidneys gradually scar and lose function. Neuropathy, nerve damage caused by reduced blood flow and the direct effects of high sugar on nerve cells, most commonly shows up as tingling, numbness, or pain in the feet and hands in a “stocking and glove” pattern. A less visible form, autonomic neuropathy, can affect digestion, heart rate, blood pressure regulation, and bladder function.
Large-vessel damage accelerates atherosclerosis, the buildup of fatty deposits in arteries. This raises the risk of heart attack, stroke, and poor circulation in the legs. Cardiovascular disease is the leading cause of death in people with long-standing type 1 diabetes. Keeping blood sugar, blood pressure, and cholesterol well managed significantly lowers these risks.
Delaying Onset in At-Risk People
Type 1 diabetes develops in stages. Stage 1 involves the appearance of autoantibodies with normal blood sugar. Stage 2 adds abnormal blood sugar readings but no symptoms. Stage 3 is full clinical diabetes. For the first time, a treatment can slow this progression. Teplizumab, an immune-modulating infusion approved in the U.S. and recommended for authorization in the EU, is indicated for adults and children aged 8 and older who are in stage 2. In clinical trials, people treated with teplizumab took a median of 50 months to progress to stage 3, compared to 25 months with placebo, roughly doubling the time before insulin dependence began.
Type 1 vs. Type 2 Diabetes
- Cause: Type 1 is autoimmune destruction of insulin-producing cells. Type 2 is primarily insulin resistance, where cells stop responding well to insulin.
- Onset: Type 1 develops over days to weeks. Type 2 develops gradually over years.
- Body weight: Type 1 is not caused by weight or lifestyle factors. Type 2 is strongly linked to excess weight and physical inactivity.
- Treatment: Type 1 always requires insulin from day one. Type 2 is often managed initially with oral medications, diet, and exercise.
- Prevention: Type 1 cannot currently be prevented, though onset can be delayed with teplizumab in eligible individuals. Type 2 can often be prevented or reversed through lifestyle changes.